It has been a mixed year for Ocular Therapeutix, Inc insiders: $461,000 bought by one person and $3.2 million sold by seven, so more selling than buying overall.
Biggest single buyer: LINDSTROM RICHARD L MD, Director, with roughly $461,000.
On the institutional side, 262 funds reported holding OCUL at the end of Q2 2026, and more funds bought than sold. Zooming out by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Heier Jeffrey S. | Executive Officer | Sell | 10,869 | $7.05 | $77K | SEC |
| Oct 6, 2026 | Kaiser Peter | Executive Officer | Sell | 9,990 | $7.05 | $70K | SEC |
| Sep 2, 2026 | Notman Donald | COO | Sell | 1,099 | $10.24 | $11K | SEC |
| Aug 26, 2026 | Kaiser Peter | Executive Officer | Sell | 3,035 | $10.77 | $33K | SEC |
| Aug 26, 2026 | Nayak Sanjay | Executive Officer | Sell | 1,897 | $10.78 | $20K | SEC |
| Aug 26, 2026 | Heier Jeffrey S. | Executive Officer | Sell | 3,296 | $10.78 | $36K | SEC |
| Aug 26, 2026 | Dugel Pravin | Officer | Sell | 21,649 | $10.77 | $233K | SEC |
| Jun 5, 2026 | Waheed Nadia | Executive Officer | Sell | 14,828 | $8.27 | $123K | SEC |
| May 28, 2026 | Dugel Pravin | Officer | Sell | 21,156 | $8.20 | $173K | SEC |
| May 28, 2026 | Kaiser Peter | Executive Officer | Sell | 2,967 | $8.20 | $24K | SEC |
| May 28, 2026 | Heier Jeffrey S. | Executive Officer | Sell | 3,018 | $8.20 | $25K | SEC |
| May 28, 2026 | Nayak Sanjay | Executive Officer | Sell | 1,858 | $8.20 | $15K | SEC |
| Feb 25, 2026 | Dugel Pravin | Officer | Sell | 20,056 | $8.28 | $166K | SEC |
| Feb 25, 2026 | Heier Jeffrey S. | Executive Officer | Sell | 3,057 | $8.28 | $25K | SEC |
| Feb 25, 2026 | Nayak Sanjay | Executive Officer | Sell | 1,759 | $8.28 | $15K | SEC |
In the last 12 months Ocular Therapeutix, Inc insiders made open-market purchases worth about $461,000 and sales worth about $3.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in OCUL was filed on 2026-10-06.
262 investment managers reported holding OCUL in SEC Form 13F filings for Q2 2026.
No congressional trades in OCUL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).